Mirion Technologies/$MIR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Mirion Technologies

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

Ticker

$MIR

Primary listing

NYSE

Industry

Electronic Equipment, Instruments & Components

Employees

2,860

ISIN

US60471A1016

MIR Metrics

BasicAdvanced
$4.2B
-
-$0.05
0.75
-

What the Analysts think about MIR

Analyst ratings (Buy, Hold, Sell) for Mirion Technologies stock.

Bulls say / Bears say

Mirion Technologies reported a 5.8% increase in revenues for Q1 2024, reaching $192.6 million, indicating strong growth momentum. (businesswire.com)
The acquisition of ec² Software Solutions is expected to enhance Mirion's software offerings in the medical sector, potentially driving future revenue growth. (biospace.com)
Mirion maintains a strong liquidity position with $175.6 million in cash and cash equivalents as of December 31, 2024, providing financial flexibility for strategic initiatives. (beyondspx.com)
Despite revenue growth, Mirion reported a net loss of $26.5 million in Q1 2024, highlighting ongoing profitability challenges. (businesswire.com)
The company's dependency on acquisitions like ec² for growth suggests potential challenges in achieving organic expansion. (stocktitan.net)
Mirion's adjusted earnings per share remained flat at $0.06 in Q1 2024 compared to the previous year, indicating stagnation in per-share profitability. (businesswire.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.

MIR Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MIR Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MIR

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs